Holocene Advisors, LP - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 372 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.08 and the average weighting 0.2%.

Quarter-by-quarter ownership
Holocene Advisors, LP ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$37,432,000
+11.8%
316,576
+26.9%
0.20%
+7.1%
Q3 2021$33,477,000
+11.1%
249,546
+34.1%
0.18%
+7.1%
Q2 2021$30,121,000
-43.6%
186,035
-72.1%
0.17%
-49.3%
Q1 2021$53,451,000
+118.6%
666,012
+48.2%
0.34%
+117.5%
Q4 2020$24,447,000449,3950.15%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Darwin Global Management, Ltd. 1,859,926$301,141,00048.58%
Burrage Capital Management LLC 63,634$10,303,00010.33%
Elmwood Wealth Management, Inc. 67,174$10,876,0005.73%
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 300,327$48,626,0004.72%
Discovery Value Fund 929,669$150,523,0004.08%
Ikarian Capital, LLC 294,400$47,667,0003.85%
Ally Bridge Group (NY) LLC 93,127$15,078,0003.75%
GREAT POINT PARTNERS LLC 100,000$16,191,0003.40%
ARK Investment Management 7,684,441$1,244,188,0002.32%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$18,043,0002.30%
View complete list of INTELLIA THERAPEUTICS INC shareholders